Русский
Sexual dysfunction in patients with chronic prostatitis and its treatment
DOI: https://dx.doi.org/10.18565/urology.2020.1.51-58
M.I. Davidov
FGBOU VO “Academician Ye. A. Vagner Perm State Medical University” of the Ministry of Healthcare of the Russian Federation, Perm, Russia
Aim: to study the frequency and type of sexual disorders in patients with chronic prostatitis (CP) and to evaluate the efficiency of Vitaprost and the biologically active complex NeuroDose in treating sexual dysfunctions.
Materials and methods. The study was conducted in 2015–2019 and consisted of two stages.
Study design: At the first stage, the frequency and type of sexual disorders were evaluated in 422 patients with CP. Standard methods for examining patients with CP included Loran-Segal questionnaire of male copulative function (MCF), International Index of Erectile Function (IIEF-5), ICEF-5, criteria of premature ejaculation, Treatment Satisfaction Visual Analogue Scale of orgasm quality and Hospital Anxiety and Depression Scale (HADS). Patients received standard 6-week complex therapy for CP. After that, at the second stage, 244 patients with sexual dysfunction (premature ejaculation, decreased intensity of orgasm) received Vitaprost and the NeuroDose biocomplex for
2 months.
Results. Sexual disorders were detected in 77% of patients with CP. The main disorders were premature ejaculation (60.9%) and decreased intensity of orgasm (43.8%), which often occurred simultaneously. Two-month therapy of sexual dysfunction with Vitaprost and NeuroDose was effective in 94.3% of patients. Good results were observed in 80.3% of cases, while satisfactory results were obtained in 14% of patients. According to MCF, total copulative function increased by 46%, the duration of sexual intercourse increased from 1.1±0.4 min to 4.1±0.4 min (p<0.001) with an absence of premature ejaculation in 81.6% of patients, the intensity of orgasm increased from 3.8±0.4 to 8.0±0.5 (p<0.001) points, and the number of patients with neuropsychiatric symptoms associated mainly with sexual dysfunction
decreased by 69.3%.
Conclusion. Premature ejaculation and decreased intensity of orgasm are the most common sexual disorders in CP, and the combination of Vitaprost and dietary supplements NeuroDose is highly effective for their treatment.
Materials and methods. The study was conducted in 2015–2019 and consisted of two stages.
Study design: At the first stage, the frequency and type of sexual disorders were evaluated in 422 patients with CP. Standard methods for examining patients with CP included Loran-Segal questionnaire of male copulative function (MCF), International Index of Erectile Function (IIEF-5), ICEF-5, criteria of premature ejaculation, Treatment Satisfaction Visual Analogue Scale of orgasm quality and Hospital Anxiety and Depression Scale (HADS). Patients received standard 6-week complex therapy for CP. After that, at the second stage, 244 patients with sexual dysfunction (premature ejaculation, decreased intensity of orgasm) received Vitaprost and the NeuroDose biocomplex for
2 months.
Results. Sexual disorders were detected in 77% of patients with CP. The main disorders were premature ejaculation (60.9%) and decreased intensity of orgasm (43.8%), which often occurred simultaneously. Two-month therapy of sexual dysfunction with Vitaprost and NeuroDose was effective in 94.3% of patients. Good results were observed in 80.3% of cases, while satisfactory results were obtained in 14% of patients. According to MCF, total copulative function increased by 46%, the duration of sexual intercourse increased from 1.1±0.4 min to 4.1±0.4 min (p<0.001) with an absence of premature ejaculation in 81.6% of patients, the intensity of orgasm increased from 3.8±0.4 to 8.0±0.5 (p<0.001) points, and the number of patients with neuropsychiatric symptoms associated mainly with sexual dysfunction
decreased by 69.3%.
Conclusion. Premature ejaculation and decreased intensity of orgasm are the most common sexual disorders in CP, and the combination of Vitaprost and dietary supplements NeuroDose is highly effective for their treatment.
Keywords: NeuroDose, vitaprost, chronic prostatitis, premature ejaculation, sexual dysfunction, treatment
About the Autors
Corresponding author: M.I. Davidov – urologist of the Highest Qualifying Category, Ph.D., associate professor at the Department of Faculty Surgery with a course of Urology of FGBOU VO “Academician Ye. A. Vagner Perm State Medical University” of the Ministry of Healthcare of the Russian Federation, Perm, Russia; e-mail: midavidov@mail.ru
Similar Articles
